U.S. Department of Health & Human Services
Open Funding Opportunities
| FOA # | FOA Title | Research Focus Area | Earliest Submission Date | Expiration Date | Posted Date Sort ascending |
|---|---|---|---|---|---|
| NOT-NS-20-044 | Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Promote Training in Clinical Research on Pain (Admin Supp – Clinical Trial Not Allowed) | Clinical Research in Pain Management | Fri, 05/15/2020 | Fri, 07/31/2020 | Fri, 04/10/2020 |
|
no summary
|
|||||
| NOT-NS-20-023 | Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | All | Wed, 04/15/2020 | Tue, 06/30/2020 | Tue, 03/03/2020 |
|
no summary
|
|||||
| RFA-HL-20-031 | Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed) | Novel Medication Options for Opioid Use Disorder and Overdose | Mon, 02/24/2020 | Thu, 06/25/2020 | Fri, 01/24/2020 |
|
no summary
|
|||||
| PAR-20-092 | Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) | Novel Medication Options for Opioid Use Disorder and Overdose | Fri, 01/24/2020 | Wed, 09/02/2020 | Fri, 01/24/2020 |
|
no summary
|
|||||
| RFA-AT-20-004 | Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) | Clinical Research in Pain Management | Sat, 02/29/2020 | Tue, 06/30/2020 | Thu, 01/23/2020 |
|
no summary
|
|||||
| RFA-NS-20-028 | Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | Clinical Research in Pain Management | Mon, 02/24/2020 | Thu, 06/25/2020 | Tue, 01/21/2020 |
|
no summary
|
|||||
| RFA-NS-20-010 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-008 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-011 | HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Fri, 10/04/2019 |
|
no summary
|
|||||
| RFA-NS-20-009 | HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Preclinical and Translational Research in Pain Management | Sun, 12/08/2019 | Fri, 09/09/2022 | Thu, 10/03/2019 |
|
no summary
|
|||||
| RFA-DA-19-019 | HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional) | New Strategies to Prevent and Treat Opioid Addiction | Sun, 12/09/2018 | Thu, 09/09/2021 | Wed, 09/25/2019 |
|
no summary
|
|||||
| RFA-DA-18-020 | NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) | Novel Medication Options for Opioid Use Disorder and Overdose | Mon, 06/25/2018 | Tue, 09/08/2020 | Wed, 09/25/2019 |
|
no summary
|
|||||